Type 2 Diabetes Drug Actos may be Associated with an Increased Risk of Bladder Cancer
In June, 2011, the U.S. Food and Drug Administration (FDA) released a warning that the type 2 diabetes drug Actos may be associated with an increased risk of bladder cancer. Studies have suggested that the increased risk of bladder cancer is as high as 40% for individuals who have taken Actos for more than twelve months.
In response to these concerns, the FDA ordered that the U.S. labeling of Actos be updated and include an updated "black box warning" against using Actos if an individual has a history of bladder cancer. The black box warning also includes information about the connection between Actos and bladder cancer. Moreover, in response to the increased bladder cancer risk, France and Germany banned the sale of Actos.
Symptoms of bladder cancer may include:
- Blood in your urine
- Frequent urination
- Painful urination
- Urinary tract infection
- Feeling an urgent need to empty your bladder
- Feeling the need to empty your bladder without results
- Needing to strain when you empty your bladder
If you or a loved one have suffered any of the above complications as a direct result of taking Actos, or have been diagnosed with bladder cancer, you may be entitled to financial compensation. Our compassionate and experienced team of product liability attorneys are here to help and will answer your questions free of charge. Contact us for a free consultation with an experienced Actos lawsuit attorney call the law firm of Freidin Dobrinsky at 1-866-495-8060.
